DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor

Paola Mazzarelli1, Paola Parrella, Davide Seripa

  • 1Laboratory of Molecular Medicine and Biotechnology, Università Campus Bio-Medico, Via Longoni, 83, Rome 00155, Italy.

Abstract

Insights

Colorectal tumors show increased DNA binding activity and protein levels of Ku70/80, a key factor in non-homologous end joining (NHEJ) DNA repair. This activation may drive chromosomal instability and cancer development.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genetics

Background:

  • The Ku70/80 heterodimer is crucial for non-homologous end joining (NHEJ), a DNA repair pathway.
  • Aberrant DNA repair mechanisms are implicated in cancer development.

Purpose of the Study:

  • To investigate the DNA binding activity and protein levels of the Ku70/80 heterodimer in human colorectal carcinogenesis.
  • To understand the role of NHEJ pathway activation in colorectal tumor formation.

Main Methods:

  • Electrophoretic mobility shift assays were used to determine Ku70/80 DNA-binding activity.
  • Immunohistochemistry and Western blot analysis assessed nuclear and cytoplasmic protein expression.
  • Samples included human colon adenomas, colorectal cancers, and matched normal colonic tissues.

Main Results:

  • Ku70/80 DNA-binding activity and nuclear protein expression were significantly increased in both adenomas and carcinomas compared to normal tissues.
  • Approximately 50% of tumors showed a clear increase in binding activity, with others showing modest increases or decreases.
  • Cytoplasmic expression of Ku70/80 was observed in pathological samples but not in normal tissues.

Conclusions:

  • The findings suggest substantial activation of the NHEJ pathway in colorectal tumors.
  • The error-prone nature of NHEJ, when abnormally activated, can contribute to chromosomal instability and tumorigenesis.
  • Ku70/80 activity and expression levels serve as potential biomarkers in colorectal cancer.